-
1
-
-
33644992605
-
What is bipolar disorder?
-
16449465 10.1176/appi.ajp.163.2.177
-
Swann AC (2006) What is bipolar disorder? Am J Psychiatry 163(2):177-179
-
(2006)
Am J Psychiatry
, vol.163
, Issue.2
, pp. 177-179
-
-
Swann, A.C.1
-
3
-
-
0018175277
-
A rating scale for mania: Reliability, validity and sensitivity
-
728692 10.1192/bjp.133.5.429 1:STN:280:DyaE1M%2FotlCktQ%3D%3D
-
Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435
-
(1978)
Br J Psychiatry
, vol.133
, pp. 429-435
-
-
Young, R.C.1
Biggs, J.T.2
Ziegler, V.E.3
Meyer, D.A.4
-
4
-
-
79958289978
-
Structural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders
-
10.2165/11590590-000000000-00000 21651312 10.2165/11590590-000000000- 00000
-
Pilla Reddy V, Kozielska M, Johnson M, Vermeulen A, de Greef R, Liu J, Groothuis GM, Danhof M, Proost JH (2011) Structural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders. Clin Pharmacokinet 50(7):429-450. doi: 10.2165/11590590-000000000-00000
-
(2011)
Clin Pharmacokinet
, vol.50
, Issue.7
, pp. 429-450
-
-
Pilla Reddy, V.1
Kozielska, M.2
Johnson, M.3
Vermeulen, A.4
De Greef, R.5
Liu, J.6
Groothuis, G.M.7
Danhof, M.8
Proost, J.H.9
-
5
-
-
0033697667
-
Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model
-
11103759 10.1067/mcp.2000.110975 1:CAS:528:DC%2BD3cXovVeru7w%3D
-
Kimko HC, Reele SS, Holford NH, Peck CC (2000) Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model. Clin Pharmacol Ther 68(5):568-577
-
(2000)
Clin Pharmacol Ther
, vol.68
, Issue.5
, pp. 568-577
-
-
Kimko, H.C.1
Reele, S.S.2
Holford, N.H.3
Peck, C.C.4
-
6
-
-
67650608192
-
Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia
-
19387434 10.1038/clpt.2009.44 1:CAS:528:DC%2BD1MXnsFemtbo%3D
-
Friberg LE, de Greef R, Kerbusch T, Karlsson MO (2009) Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia. Clin Pharmacol Ther 86(1):84-91
-
(2009)
Clin Pharmacol Ther
, vol.86
, Issue.1
, pp. 84-91
-
-
Friberg, L.E.1
De Greef, R.2
Kerbusch, T.3
Karlsson, M.O.4
-
7
-
-
61449255220
-
Evaluation of structural models to describe the effect of placebo upon the time course of major depressive disorder
-
19205853 10.1007/s10928-009-9110-3
-
Shang EY, Gibbs MA, Landen JW, Krams M, Russell T, Denman NG, Mould DR (2009) Evaluation of structural models to describe the effect of placebo upon the time course of major depressive disorder. J Pharmacokinet Pharmacodyn 36(1):63-80
-
(2009)
J Pharmacokinet Pharmacodyn
, vol.36
, Issue.1
, pp. 63-80
-
-
Shang, E.Y.1
Gibbs, M.A.2
Landen, J.W.3
Krams, M.4
Russell, T.5
Denman, N.G.6
Mould, D.R.7
-
8
-
-
0026471544
-
Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine
-
1454836 10.1073/pnas.89.23.11471 1:CAS:528:DyaK3sXntlGgtg%3D%3D
-
Holford NH, Peace KE (1992) Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine. Proc Natl Acad Sci USA 89(23):11471-11475
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, Issue.23
, pp. 11471-11475
-
-
Holford, N.H.1
Peace, K.E.2
-
9
-
-
73349136256
-
Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease
-
19521783 10.1208/s12248-009-9123-2 1:CAS:528:DC%2BD1MXhsFGmur7M
-
Bhattaram VA, Siddiqui O, Kapcala LP, Gobburu JV (2009) Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease. AAPS J 11(3):456-464
-
(2009)
AAPS J
, vol.11
, Issue.3
, pp. 456-464
-
-
Bhattaram, V.A.1
Siddiqui, O.2
Kapcala, L.P.3
Gobburu, J.V.4
-
10
-
-
79952576381
-
-
Panel on Handing Missing Data in Clinical Trials, National Research Council The National Academies Press, Washington, DC
-
Panel on Handing Missing Data in Clinical Trials, National Research Council (2010) The prevention and treatment of missing data in clinical trials. The National Academies Press, Washington, DC
-
(2010)
The Prevention and Treatment of Missing Data in Clinical Trials
-
-
-
11
-
-
58049191296
-
Modelling placebo response in depression trials using a longitudinal model with informative dropout
-
10.1016/j.ejps.2008.10.025 19041717 10.1016/j.ejps.2008.10.025 1:CAS:528:DC%2BD1MXhsFSntg%3D%3D
-
Gomeni R, Lavergne A, Merlo-Pich E (2009) Modelling placebo response in depression trials using a longitudinal model with informative dropout. Eur J pharm Sci 36(1):4-10. doi: 10.1016/j.ejps.2008.10.025
-
(2009)
Eur J Pharm Sci
, vol.36
, Issue.1
, pp. 4-10
-
-
Gomeni, R.1
Lavergne, A.2
Merlo-Pich, E.3
-
12
-
-
84878763807
-
Clinical trial simulation of outcome after accounting for high dropout typical of acute pain studies
-
Paper presented, Chicago
-
Dutta S, Diderichsen P, Liu W (2011) Clinical trial simulation of outcome after accounting for high dropout typical of acute pain studies. Paper presented at the American College of Clinical Pharmacology 40th Annual Meeting, Chicago
-
(2011)
American College of Clinical Pharmacology 40th Annual Meeting
-
-
Dutta, S.1
Diderichsen, P.2
Liu, W.3
-
13
-
-
0038402581
-
A joint model for nonlinear longitudinal data with informative dropout
-
12800808 10.1023/A:1023249510224
-
Hu C, Sale ME (2003) A joint model for nonlinear longitudinal data with informative dropout. J Pharmacokinet Pharmacodyn 30(1):83-103
-
(2003)
J Pharmacokinet Pharmacodyn
, vol.30
, Issue.1
, pp. 83-103
-
-
Hu, C.1
Sale, M.E.2
-
16
-
-
65249191379
-
Quantitative disease, drug, and trial models
-
10.1146/annurev.pharmtox.011008.145613 18851702 10.1146/annurev.pharmtox. 011008.145613 1:CAS:528:DC%2BD1MXisV2jsb8%3D
-
Gobburu JV, Lesko LJ (2009) Quantitative disease, drug, and trial models. Annu Rev Pharmacol Toxicol 49:291-301. doi: 10.1146/annurev.pharmtox.011008. 145613
-
(2009)
Annu Rev Pharmacol Toxicol
, vol.49
, pp. 291-301
-
-
Gobburu, J.V.1
Lesko, L.J.2
-
17
-
-
79953756267
-
Estimating transformations for repeated measures modeling of continuous bounded outcome data
-
doi: 10.1002/sim.4155
-
Hutmacher MM, French JL, Krishnaswami S, Menon S (2011) Estimating transformations for repeated measures modeling of continuous bounded outcome data. Stat Med. doi: 10.1002/sim.4155
-
(2011)
Stat Med.
-
-
Hutmacher, M.M.1
French, J.L.2
Krishnaswami, S.3
Menon, S.4
-
18
-
-
80052591773
-
Bounded outcome score modeling: Application to treating psoriasis with ustekinumab
-
10.1007/s10928-011-9205-5 21688068 10.1007/s10928-011-9205-5 1:CAS:528:DC%2BC3MXovVyntbo%3D
-
Hu C, Yeilding N, Davis HM, Zhou H (2011) Bounded outcome score modeling: application to treating psoriasis with ustekinumab. J Pharmacokinet Pharmacodyn 38(4):497-517. doi: 10.1007/s10928-011-9205-5
-
(2011)
J Pharmacokinet Pharmacodyn
, vol.38
, Issue.4
, pp. 497-517
-
-
Hu, C.1
Yeilding, N.2
Davis, H.M.3
Zhou, H.4
-
19
-
-
41149144295
-
Mechanisms of placebo and placebo-related effects across diseases and treatments
-
10.1146/annurev.pharmtox.48.113006.094711 17666008 10.1146/annurev. pharmtox.48.113006.094711 1:CAS:528:DC%2BD1cXisFynurg%3D
-
Benedetti F (2008) Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 48:33-60. doi: 10.1146/annurev.pharmtox.48.113006.094711
-
(2008)
Annu Rev Pharmacol Toxicol
, vol.48
, pp. 33-60
-
-
Benedetti, F.1
-
20
-
-
34247325672
-
Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials
-
10.1111/j.1365-2125.2006.02815.x 17488364 10.1111/j.1365-2125.2006.02815. x
-
Gomeni R, Merlo-Pich E (2007) Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. Br J Clin Pharmacol 63(5):595-613. doi: 10.1111/j.1365-2125.2006.02815.x
-
(2007)
Br J Clin Pharmacol
, vol.63
, Issue.5
, pp. 595-613
-
-
Gomeni, R.1
Merlo-Pich, E.2
-
21
-
-
67651171223
-
Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development
-
19440187 10.1038/clpt.2009.64 1:CAS:528:DC%2BD1MXovFOrt7o%3D
-
Wang Y, Sung C, Dartois C, Ramchandani R, Booth BP, Rock E, Gobburu J (2009) Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development. Clin Pharmacol Ther 86(2):167-174
-
(2009)
Clin Pharmacol Ther
, vol.86
, Issue.2
, pp. 167-174
-
-
Wang, Y.1
Sung, C.2
Dartois, C.3
Ramchandani, R.4
Booth, B.P.5
Rock, E.6
Gobburu, J.7
-
22
-
-
47149107776
-
Approaches to handling pharmacodynamic baseline responses
-
10.1007/s10928-008-9088-2 18446428 10.1007/s10928-008-9088-2 1:CAS:528:DC%2BD1cXosVGiu74%3D
-
Dansirikul C, Silber HE, Karlsson MO (2008) Approaches to handling pharmacodynamic baseline responses. J Pharmacokinet Pharmacodyn 35(3):269-283. doi: 10.1007/s10928-008-9088-2
-
(2008)
J Pharmacokinet Pharmacodyn
, vol.35
, Issue.3
, pp. 269-283
-
-
Dansirikul, C.1
Silber, H.E.2
Karlsson, M.O.3
-
23
-
-
50349085673
-
Identifying patterns in treatment response profiles in acute bipolar mania: A cluster analysis approach
-
18664256 10.1186/1471-244X-8-65
-
Lipkovich IA, Houston JP, Ahl J (2008) Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach. BMC Psychiatry 8:65
-
(2008)
BMC Psychiatry
, vol.8
, pp. 65
-
-
Lipkovich, I.A.1
Houston, J.P.2
Ahl, J.3
-
24
-
-
84867862609
-
Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome
-
10.1371/journal.pone.0048135 23110189 10.1371/journal.pone.0048135 1:CAS:528:DC%2BC38Xhs1Gjt7fE
-
Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, Conboy LA, Kelley JM, Kokkotou E, Kaptchuk TJ (2012) Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One 7(10):e48135. doi: 10.1371/journal.pone.0048135
-
(2012)
PLoS One
, vol.7
, Issue.10
, pp. 48135
-
-
Hall, K.T.1
Lembo, A.J.2
Kirsch, I.3
Ziogas, D.C.4
Douaiher, J.5
Jensen, K.B.6
Conboy, L.A.7
Kelley, J.M.8
Kokkotou, E.9
Kaptchuk, T.J.10
-
25
-
-
57049188862
-
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
-
10.1016/j.euroneuro.2008.08.009 18823760 10.1016/j.euroneuro.2008.08.009 1:CAS:528:DC%2BD1cXhsVKrsb7N
-
Papakostas GI, Fava M (2009) Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009
-
(2009)
Eur Neuropsychopharmacol
, vol.19
, Issue.1
, pp. 34-40
-
-
Papakostas, G.I.1
Fava, M.2
-
26
-
-
77950328267
-
Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses
-
10.4088/JCP.08r04516blu 20122371 10.4088/JCP.08r04516blu 1:CAS:528:DC%2BC3cXlsFSjsr8%3D
-
Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctot KL (2010) Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin psychiatry 71(3):270-279. doi: 10.4088/JCP.08r04516blu
-
(2010)
J Clin Psychiatry
, vol.71
, Issue.3
, pp. 270-279
-
-
Sinyor, M.1
Levitt, A.J.2
Cheung, A.H.3
Schaffer, A.4
Kiss, A.5
Dowlati, Y.6
Lanctot, K.L.7
-
27
-
-
0032733161
-
Unbalanced randomization influences placebo response: Scientific versus ethical issues around the use of placebo in migraine trials
-
10570722 10.1046/j.1468-2982.1999.019008699.x 1:STN:280: DC%2BD3c%2FjsleisA%3D%3D
-
Diener HC, Dowson AJ, Ferrari M, Nappi G, Tfelt-Hansen P (1999) Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia 19(8):699-700
-
(1999)
Cephalalgia
, vol.19
, Issue.8
, pp. 699-700
-
-
Diener, H.C.1
Dowson, A.J.2
Ferrari, M.3
Nappi, G.4
Tfelt-Hansen, P.5
-
28
-
-
79951579481
-
Signal detection and placebo response in schizophrenia: Parallels with depression
-
20581800
-
Mallinckrodt CH, Zhang L, Prucka WR, Millen BA (2010) Signal detection and placebo response in schizophrenia: parallels with depression. Psychopharmacol Bull 43(1):53-72
-
(2010)
Psychopharmacol Bull
, vol.43
, Issue.1
, pp. 53-72
-
-
Mallinckrodt, C.H.1
Zhang, L.2
Prucka, W.R.3
Millen, B.A.4
-
29
-
-
79956339016
-
The placebo response in clinical trials: More questions than answers
-
10.1098/rstb.2010.0384 21576146 10.1098/rstb.2010.0384
-
Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S (2011) The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci 366(1572):1889-1895. doi: 10.1098/rstb.2010.0384
-
(2011)
Philos Trans R Soc Lond B Biol Sci
, vol.366
, Issue.1572
, pp. 1889-1895
-
-
Enck, P.1
Klosterhalfen, S.2
Weimer, K.3
Horing, B.4
Zipfel, S.5
-
30
-
-
79955486643
-
Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications
-
10.4088/JCP.10m06191 21527123 10.4088/JCP.10m06191
-
Khin NA, Chen YF, Yang Y, Yang P, Laughren TP (2011) Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. J Clin Psychiatry 72(4):464-472. doi: 10.4088/JCP.10m06191
-
(2011)
J Clin Psychiatry
, vol.72
, Issue.4
, pp. 464-472
-
-
Khin, N.A.1
Chen, Y.F.2
Yang, Y.3
Yang, P.4
Laughren, T.P.5
-
31
-
-
84863550159
-
Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration
-
10.4088/JCP.11r07539 22687813 10.4088/JCP.11r07539
-
Khin NA, Chen YF, Yang Y, Yang P, Laughren TP (2012) Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. J Clin Psychiatry 73(6):856-864. doi: 10.4088/JCP.11r07539
-
(2012)
J Clin Psychiatry
, vol.73
, Issue.6
, pp. 856-864
-
-
Khin, N.A.1
Chen, Y.F.2
Yang, Y.3
Yang, P.4
Laughren, T.P.5
|